Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» generics
generics
Abbott divests 60% of its stake in Mylan
Mass Device
Sat, 03/25/17 - 11:19 am
Abbott Labs
Mylan Labs
generics
Crunch week looms for Sanofi, Roche and GSK at U.S. drugs agency
Yahoo/Reuters
Thu, 03/23/17 - 09:32 am
Sanofi
Roche
GSK
FDA
Ocrevus
MS
Dupixent
eczema
generics
Advair
Mylan Labs
Copying Valeant's Xifaxan just got 'a lot easier,' thanks to new FDA guidance: analyst
Fierce Pharma
Tue, 03/21/17 - 06:58 pm
Valeant Pharmaceuticals
Xifaxan
generics
FDA
IBS-d
Here’s one drug safety rule the FDA should enact — quickly
Stat
Mon, 03/20/17 - 11:17 pm
FDA
drug safety
generics
Pharmaceutical Industry Cannibalization: The Launch of Authorized Generics After the Loss of Market Exclusivity
Xtalks
Mon, 03/13/17 - 10:11 am
generics
FDA
FTC
market exclusivity
Glaxo serves up 20% payer discounts on Advair to soften generic blow
Fierce Pharma
Mon, 03/6/17 - 09:44 am
GSK
payers
payer discounts
Advair
generics
Mylan Labs
Inside Sanofi’s Consumer Healthcare and Generics Strategy
Market Realist
Tue, 02/21/17 - 11:09 am
Sanofi
consumer healthcare
generics
Amgen and the BPCIA Patent Dance – Redux
FDA Law Blog
Mon, 02/20/17 - 10:07 am
Amgen
patents
BPCIA
FDA
Sandoz
Neupogen
generics
Genentech
Avastin
Teva catches break as warning letter looks to delay Momenta Copaxone generic
Fierce Pharma
Mon, 02/20/17 - 10:06 am
Teva Pharmaceutical
Momenta
Copaxone
MS
multiple sclerosis
generics
If copies of Teva's Copaxone hit, oral MS rivals could be the real threat
Fierce Pharma
Wed, 02/15/17 - 09:41 am
Teva Pharmaceutical
Copaxone
MS
multiple sclerosis
generics
Tecfidera
Biogen
Gilenya
Novartis
Aubagio
Sanofi
Why Did That Drug Price Increase 6,000%? It's The Law
Forbes
Sat, 02/11/17 - 12:40 pm
drug pricing
deflazacort
generics
Duchenne Muscular Dystrophy
Emflaza
Marathon Pharma
Generic threat hangs over GlaxoSmithKline's Advair
BioPharma Dive
Fri, 02/10/17 - 10:04 am
generics
GSK
Advair
asthma
How does GSK's incoming chief view the Advair generic threat? Stay tuned this week
Fierce Pharma
Tue, 02/7/17 - 10:24 am
Pharma CEOs
GSK
generics
Advair
Emma Walmsley
BioMarin sues to stop generic version of its $90K-a-year drug
Bizjournals.com
Mon, 02/6/17 - 10:04 pm
Biomarin
generics
Kuvan
Dr Reddy's
California Sues Teva, Allergan for Allegedly Blocking Generic Competition to Lidoderm
Motley Fool
Sun, 02/5/17 - 12:20 pm
California
Teva Pharmaceutical
Allergan
generics
Endo International
lidoderm
Teva Confirms Generic Victoza® Patent Challenge in the United States
Yahoo
Thu, 02/2/17 - 09:20 am
Teva Pharmaceutical
patents
diabetes
Victoza
generics
Novo Nordisk
Are Teva Pharmaceutical's Best Days Behind It?
Motley Fool
Wed, 02/1/17 - 05:36 pm
Teva Pharmaceutical
Copaxone
generics
patents
MS
multiple sclerosis
Fighting a generic onslaught, Novartis adds CAR-T to its growing list of late-stage blockbusters
Endpoints
Wed, 01/25/17 - 09:55 am
Novartis
generics
CAR-T
FDA approves generic version of Jazz Pharma's sleep disorder drug
Yahoo/Reuters
Tue, 01/17/17 - 10:10 pm
FDA
generics
Jazz Pharmaceuticals
Xyrem
narcolepsy
Generic EpiPen Hits CVS Shelves at Just Over $100 for Two-Pack
Xtalks
Mon, 01/16/17 - 10:32 am
EpiPens
generics
Mylan Labs
drug pricing
CVS
Pages
« first
‹ previous
…
27
28
29
30
31
32
33
34
35
…
next ›
last »